New Delhi [India], June 9 (ANI): The Central Industrial Security Force will take over security of the Hyderabad campus of Bharat Biotech, one of the major COVID-19 vaccine manufacturers in the country, informed CISF on Tuesday.
Pune (Maharashtra) [India], June 8 (ANI/BusinessWire India): CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV.
New Delhi [India], June 6 (ANI): The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown COVID-19 vaccine, Bharat Biotech's Covaxin, from Monday, sources said.
Hyderabad [Telangana] , June 5 (ANI): Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday.
New Delhi [India], June 4 (ANI): India's first indigenous tumour antigen, SPAG9 discovered by Dr Anil Suri, head of Cancer Research Program at Delhi based National Institute of Immunology (NII), an Autonomous Institute of Department of Biotechnology (DBT), in 1998 has received the trademark
New Delhi [India], June 4 (ANI): Delhi government on Friday told the Delhi High Court that Bharat Biotech supplied only 1.5 lakh doses of COVID-19 vaccine 'Covaxin' in May against a promise of five lakh doses.
New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12, 2021, the Drug Controller General of India (DCGI) has permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 years to 18 years of age for its vacc
Hyderabad (Telangana) [India], June 3 (ANI): Hyderabad-based Bharat Biotech on Thursday said that biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation rights of its COVID-19 vaccine Covaxin in Canada, in addition to its existing Uni
New Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday.
Patna (Bihar) [India], June 3 (ANI): Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin.
New Delhi [India], May 31 (ANI): With ramping up of production capacities, nearly 25 crore ‘Made in India’ vaccine doses are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore peopl
New Delhi [India], May 29 (ANI): Congress leader P Chidambaram said on Saturday that the mystery of the "missing vaccines" is deepening every day and a CAG driven full-scope audit of capacity, production, despatch, supply and customers' lists of two domestic manufacturers of COVID-19 vaccin